Retrospective claims analysis of physical therapy utilization among women with stress or mixed urinary incontinence.
health economics
healthcare resource utilization
physical therapy
rehabilitation
urinary incontinence
Journal
Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
23
12
2021
accepted:
07
03
2022
pubmed:
31
3
2022
medline:
30
4
2022
entrez:
30
3
2022
Statut:
ppublish
Résumé
To describe the characteristics of women with stress or mixed urinary incontinence (SUI/MUI) receiving physical therapy (PT) services, including referral patterns and PT utilization. Female patients with claims associated with an SUI or MUI diagnosis (International Classification of Disease-Clinical Modification [ICD-9-CM]: 625.6, 788.33, or ICD-10-CM: N39.3, N39.46) between July 01, 2014 and June 30, 2016 were identified in International business machines (IBM)'s MarketScan Research Database. Inclusion criteria included the absence of pregnancy claims and ≥80% medical and pharmacy enrollment pre- and postindex. First SUI/MUI diagnosis claim determined index. Patients were followed for 2 years, and associated UI-associated PT encounters were identified. Descriptive statistics were calculated for patients with at least one PT visit during the postindex period. In a cohort of 103,813 women with incident SUI or MUI diagnosis, 2.6% (2792/103,813) had at least one PT visit in the 2 years following their diagnosis. Mean age at index PT encounter was 50.55 years. A total of 52.36% (1462/2792) women had one to four PT visits; 21.2% (592/2792) had >8 PT visits. In subanalysis of the PT cohort (1345/2792), women who received PT only had the lowest average 2-year postindex total medical cost (mean: $12,671; SD: $16,346), compared with PT plus medications (mean: $27,394; SD: $64,481), and PT plus surgery (mean: $33,656; SD: $26,245), respectively. Over 40% had their first PT visit ≥3 months after their index date. The percentage of women with a PT visit associated with an incident SUI or MUI diagnosis was low (2.6%), and 30% of this group completed three or more PT visits. This suggests poor adherence to clinical guidelines regarding supervised treatment of UI in women. Our study suggests underutilization of PT among insured women with SUI and MUI in the 2 years following diagnosis. Interventions to improve this gap in first-line care may represent an opportunity for an increased role for PTs in the care of women with UI.
Identifiants
pubmed: 35353916
doi: 10.1002/nau.24913
pmc: PMC9311701
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
918-925Informations de copyright
© 2022 Renovia Inc. Neurourology and Urodynamics published by Wiley Periodicals LLC.
Références
BMC Womens Health. 2009 Sep 14;9:26
pubmed: 19751517
BJU Int. 2015 Dec;116(6):955-64
pubmed: 25683075
J Eval Clin Pract. 2009 Oct;15(5):782-8
pubmed: 19811589
Neurourol Urodyn. 2022 Apr;41(4):918-925
pubmed: 35353916
Cochrane Database Syst Rev. 2014 May 14;(5):CD005654
pubmed: 24823491
Int Urogynecol J. 2013 Aug;24(8):1361-9
pubmed: 23291858
Neurourol Urodyn. 2010;29(1):4-20
pubmed: 19941278
Int Urogynecol J. 2012 Aug;23(8):1087-93
pubmed: 22527544
Acta Obstet Gynecol Scand. 2012 Aug;91(8):901-10
pubmed: 22497363
Am J Obstet Gynecol. 2010 May;202(5):483.e1-4
pubmed: 20227673
Phys Ther. 2011 Nov;91(11):1664-72
pubmed: 21949433
Int Urogynecol J. 2016 May;27(5):763-72
pubmed: 26670573
PM R. 2018 Jun;10(6):601-606
pubmed: 29138041
J Eval Clin Pract. 2008 Oct;14(5):807-11
pubmed: 18462277
Int Urogynecol J. 2013 Nov;24(11):1947-51
pubmed: 23702666
BJOG. 2009 Apr;116(5):719-25
pubmed: 19298440
Am J Obstet Gynecol. 2018 May;218(5):502.e1-502.e8
pubmed: 29425839
BJU Int. 2016 Jan;117(1):20-33
pubmed: 26033093
BMC Fam Pract. 2019 May 23;20(1):70
pubmed: 31122187
Int Urogynecol J. 2020 Jun;31(6):1063-1089
pubmed: 32342112
Am J Obstet Gynecol. 2020 Feb;222(2):163.e1-163.e8
pubmed: 31449803
JMIR Mhealth Uhealth. 2020 Jun 12;8(6):e17114
pubmed: 32530431
Phys Ther. 2016 Oct;96(10):1597-1609
pubmed: 27149960
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006632
pubmed: 20238347
Female Pelvic Med Reconstr Surg. 2018 Mar/Apr;24(2):155-160
pubmed: 29474290
J Med Internet Res. 2019 Mar 14;21(3):e11296
pubmed: 30869644
Curr Urol Rep. 2016 Feb;17(2):10
pubmed: 26757904
BMC Med. 2016 Feb 23;14:35
pubmed: 26904977
J Gynecol Obstet Hum Reprod. 2020 Oct;49(8):101842
pubmed: 32592767
Female Pelvic Med Reconstr Surg. 2012 Nov-Dec;18(6):340-3
pubmed: 23143427
Am J Obstet Gynecol. 2013 Dec;209(6):584.e1-5
pubmed: 24036399
Int Urogynecol J. 2020 May;31(5):887-893
pubmed: 31463525
Ann Intern Med. 2014 Sep 16;161(6):429-40
pubmed: 25222388
J Urol. 2019 Aug;202(2):333-338
pubmed: 30865568
BMJ Open. 2018 Nov 13;8(11):e020962
pubmed: 30429142
Obstet Gynecol. 2018 May;131(5):e140-e150
pubmed: 29683911
Female Pelvic Med Reconstr Surg. 2017 Nov/Dec;23(6):444-448
pubmed: 28145917
Obstet Gynecol. 2022 Apr 1;139(4):606-615
pubmed: 35271539
BJOG. 2011 Dec;118(13):1592-600
pubmed: 21895954
Curr Urol Rep. 2011 Oct;12(5):358-62
pubmed: 21847532
Obstet Gynecol. 2009 Dec;114(6):1278-1283
pubmed: 19935030
Ann Intern Med. 2018 Sep 4;169(5):311-319
pubmed: 30105353
Can Urol Assoc J. 2010 Dec;4(6):419-24
pubmed: 21191506
J Urol. 2011 Aug;186(2):589-93
pubmed: 21684555
Curr Opin Obstet Gynecol. 2015 Oct;27(5):380-4
pubmed: 26308198